欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
CY/H/0110/004
药品名称
Lapozan 10 mg Filmtabletten
活性成分
olanzapine 10.0 mg
剂型
Film-coated tablet
上市许可持有人
Medochemie Ltd. P.O.Box 51409 3505 Limassol Cyprus
参考成员国 - 产品名称
Cyprus (CY)
互认成员国 - 产品名称
Greece (GR)
Latvia (LV)
Lapozan 10 mg apvalkotās tabletes
Lithuania (LT)
Lapozan 10 mg plėvele dengtos tabletės
Bulgaria (BG)
Lapozan
Romania (RO)
Lapozan 10 mg comprimate filmate
Slovakia (SK)
Lapozan 10mg
许可日期
2009/08/31
最近更新日期
2024/01/02
药物ATC编码
N05AH03 olanzapine
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final Labelling
|
DE1852_Lapozan_labelling_oro_clean_20140924_renewal
Date of last change:2024/09/06
Final Labelling
|
DE1852_Lapozan_labelling_tabs_clean_20140924_renewal
Date of last change:2024/09/06
Final PL
|
DE1852_Lapozan_pil_oro_clean_20140924_renewal
Date of last change:2024/09/06
Final PL
|
DE1852_Lapozan_pil_tabs_clean_20140924_renewal
Date of last change:2024/09/06
Final SPC
|
DE1852_Lapozan_spc_oro_clean_20140924_renewal
Date of last change:2024/09/06
Final SPC
|
DE1852_Lapozan_spc_tabs_clean_20140924_renewal
Date of last change:2024/09/06
PubAR
|
PAREN_DE1852_Olanzapin_20100310_final
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase